[go: up one dir, main page]

BR0010709A - Gonadotrofinas - Google Patents

Gonadotrofinas

Info

Publication number
BR0010709A
BR0010709A BR0010709-3A BR0010709A BR0010709A BR 0010709 A BR0010709 A BR 0010709A BR 0010709 A BR0010709 A BR 0010709A BR 0010709 A BR0010709 A BR 0010709A
Authority
BR
Brazil
Prior art keywords
gonadotropins
anovulatory women
folliculogenesis
induce
gonadotrofinas
Prior art date
Application number
BR0010709-3A
Other languages
English (en)
Other versions
BR0010709B1 (pt
Inventor
Stephen Franks
Stephen Hillier
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8241371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0010709(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of BR0010709A publication Critical patent/BR0010709A/pt
Publication of BR0010709B1 publication Critical patent/BR0010709B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"GONADOTROFINAS". A presente invenção refere-se ao uso de gonadotrofinas na indução de foliculogênese em mulheres anovulatórias. Em particular, ela refere-se ao uso de LH ( ou uma dose equivalente de hCG ) na produção de um medicamento para a indução de foliculogênese em mulheres anovulatórias em doses diárias especificadas. Em certas concretizações, LH pode ser usado em combinação com FSH.
BRPI0010709-3A 1999-05-07 2000-05-05 uso de lh para a produção de um medicamento para induzir a paucifoliculogênese ou unifoliculogênese em mulheres anovulatórias. BR0010709B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99303574 1999-05-07
PCT/GB2000/001745 WO2000067778A1 (en) 1999-05-07 2000-05-05 Gonadotrophins

Publications (2)

Publication Number Publication Date
BR0010709A true BR0010709A (pt) 2002-06-04
BR0010709B1 BR0010709B1 (pt) 2011-11-29

Family

ID=8241371

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0010709-3A BR0010709B1 (pt) 1999-05-07 2000-05-05 uso de lh para a produção de um medicamento para induzir a paucifoliculogênese ou unifoliculogênese em mulheres anovulatórias.

Country Status (18)

Country Link
US (2) US7695721B1 (pt)
EP (1) EP1176976B2 (pt)
JP (1) JP4975215B2 (pt)
CN (1) CN1352566A (pt)
AR (1) AR023869A1 (pt)
AT (1) ATE332705T1 (pt)
AU (1) AU4592800A (pt)
BR (1) BR0010709B1 (pt)
CA (1) CA2372714A1 (pt)
DE (1) DE60029318T3 (pt)
DK (1) DK1176976T4 (pt)
ES (1) ES2267531T5 (pt)
HK (1) HK1045261A1 (pt)
IL (2) IL146252A0 (pt)
PT (1) PT1176976E (pt)
SI (1) SI1176976T2 (pt)
TW (1) TWI242440B (pt)
WO (1) WO2000067778A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002324183B2 (en) * 2001-09-12 2007-10-25 Merck Serono Sa Use of hCG and LH in controlled ovarian hyperstimulation
HRP20040087A2 (en) * 2001-09-12 2004-12-31 Applied Research Systems USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION
CA2457851A1 (en) 2001-09-12 2003-03-20 Applied Research Systems Ars Holding N.V. Use of hcg and lh in controlled ovarian hyperstimulation
ES2322136T3 (es) * 2001-09-12 2009-06-17 Laboratoires Serono Sa Uso de lh la hiperestimulacion ovarica controlada.
EP1596881B1 (en) * 2003-02-07 2008-12-10 Austria Wirtschaftsservice Gesellschaft mit beschränkter Haftung Use of human chorionic gonadotropin in the treatment of symptoms caused by endometriosis
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
PT1638595E (pt) 2003-06-20 2013-04-26 Ares Trading Sa Fsh liofilizada / formulações de hl
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
HUE025514T2 (en) * 2010-09-29 2016-02-29 Ferring Bv Preparation for use in treating infertility
WO2012127501A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for improving endometrial thickness during ovarian stimulation
WO2013010840A2 (en) 2011-07-18 2013-01-24 Arts Biologics A/S Long acting biologically active luteinizing hormone (lh) compound
US20150150497A1 (en) * 2012-07-18 2015-06-04 Mor Research Applications Ltd. Intrauterine device
US11389133B2 (en) 2016-10-28 2022-07-19 Samsung Electronics Co., Ltd. Method and apparatus for follicular quantification in 3D ultrasound images
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
IT202000022015A1 (it) * 2020-09-18 2022-03-18 Marca Antonio La Nuovo uso dell'ormone luteinizzante

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1197570B (it) * 1983-02-11 1988-12-06 Serono Ist Farm Miscele di fsh e lh da ipofisi porcine in rapporto definito
US4845077A (en) * 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
US4725579A (en) 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins
US5162306A (en) * 1987-01-23 1992-11-10 Donaldson Lloyd E Composition and method for producing superovulation in mammals
DK49987A (da) * 1987-01-30 1988-07-31 Nordisk Gentofte Fremgangsmaade til behandling af infertilitet og middel til anvendelse ved fremgangsmaaden
US5356876A (en) 1992-01-13 1994-10-18 Trinity University Methods of terminating pregnancy
WO2000032222A1 (en) * 1998-12-01 2000-06-08 Akzo Nobel N.V. Improvement of folliculogenesis

Also Published As

Publication number Publication date
JP2002544168A (ja) 2002-12-24
TWI242440B (en) 2005-11-01
EP1176976B1 (en) 2006-07-12
EP1176976B2 (en) 2015-10-21
JP4975215B2 (ja) 2012-07-11
HK1045261A1 (zh) 2002-11-22
US7151083B2 (en) 2006-12-19
CA2372714A1 (en) 2000-11-16
DE60029318T8 (de) 2007-11-22
US20040224895A1 (en) 2004-11-11
WO2000067778A1 (en) 2000-11-16
DE60029318D1 (de) 2006-08-24
DE60029318T2 (de) 2007-08-09
BR0010709B1 (pt) 2011-11-29
DE60029318T3 (de) 2016-03-10
ES2267531T3 (es) 2007-03-16
CN1352566A (zh) 2002-06-05
SI1176976T2 (sl) 2015-12-31
AR023869A1 (es) 2002-09-04
DK1176976T4 (en) 2015-11-02
ES2267531T5 (es) 2015-11-24
EP1176976A1 (en) 2002-02-06
SI1176976T1 (sl) 2006-10-31
ATE332705T1 (de) 2006-08-15
IL146252A (en) 2010-06-30
US7695721B1 (en) 2010-04-13
PT1176976E (pt) 2006-11-30
DK1176976T3 (da) 2006-11-13
IL146252A0 (en) 2002-07-25
AU4592800A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
BR0010709A (pt) Gonadotrofinas
HN1998000155A (es) Medicamentos
PA8479201A1 (es) Derivados del acido hidroxi-pipecolato hidroxamico
BR9911408A (pt) Formas de dosagem contendo apomorfina paramelhora de disfunção erétil masculina
PL327146A1 (en) Antagonists of the gonadotrophin liberating hormone
ITMI932122A1 (it) Chiodo endomidollare bloccato adatto in particolare per omero
BR0115067A (pt) Análogos de gnrh para tratamento de incontinência urinária
AP1893A (en) Compounds specific to adenosine A1, A2A and A3 receptor and uses thereof
BR0107535A (pt) Uso de carotenóides e forma de dosagem unitária destes
IL154888A0 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
BRPI0304291B8 (pt) Absorvente higiênico.
MY120802A (en) Absorbent article.
ES2189768T3 (es) Sintesis regioselectiva de derivados de rapamicina.
BR0210013A (pt) Gel oftálmico de pirenzepina
BR0009524A (pt) Uso de um composto, e, composição farmacêutica ou veterinaria
MXPA02010316A (es) Terapia novedosa para los trastornos asociados con la hiperlipidemia.
BR0113148A (pt) Composições de 2-piridinamina e métodos relacionados
ITMI992107A0 (it) Uso del baclofen nel trattamento dell'astinenza da etanolo
MY117307A (en) New harmone medicaments and their use for correction of oestrogen deficiencies.
BRPI0012553B8 (pt) pastilha contendo cloridrato de ambroxol, seu processo de preparação e seu uso
AR020832A1 (es) Procedimiento para la preparacion de una composicion de alta pureza de (7alfa, 17alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5-(10)-en-20-in-3-ona
CY1107227T1 (el) Θεραπεια αυτοανοσων νοσων με εκχυλισμα αμερικανικου γκινσενγκ
BR0010499A (pt) Agentes endoparasiticidas
AR007058A1 (es) Uso de interferon en medicamentos y composiciones para contacto oromucosal
GR990100373A (el) Σταθερες συνθεσεις διαλυματων απομορφινης

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: LABORATOIRES SERONO S.A. (CH)

Free format text: TRANSFERIDO DE: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/11/2011, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time
B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)